Microsoft faces a paradox: thriving financially, yet undergoing significant layoffs. Satya Nadella acknowledged the "enigma ...

Cigna's earnings report is coming soon, so investors are on edge. Will Cigna surpass Wall Street's estimates, or will it fall ...

In a turbulent market, Blackstone Inc showcased a robust Q2 2025, with a sharp increase in assets under management (AUM) and ...

Thermo Fisher Scientific Inc. just made headlines with its hefty $17.6 billion acquisition of PPD, Inc., aiming to bolster ...

UBS remains bullish on Merck, reiterating its Buy rating with a $105 price target. This optimism follows Merck's planned $10 ...

Freemont Management S.A. just made a splash, investing $2.95 million in Salesforce. But they aren't the only ones shaking ...

Abbott Laboratories might just be the prescription for your portfolio. The company is sitting pretty thanks to strong ...

Seaport Res Ptn has updated its Q3 earnings forecast for Morgan Stanley, pushing the EPS estimate from $2.03 to $2.09. This ...

The U.S. railroad sector is buzzing with the news of Union Pacific and Norfolk Southern's potential $200 billion merger, ...

Calton & Associates trimmed its Bank of America holdings by 60.5% in Q1. They now hold 7,013 shares, worth $293,000. Other ...

Eli Lilly's Alzheimer's drug, donanemab (Kisqali), just got a thumbs-up from the European Medicines Agency's (EMA) expert ...

Pfizer saw a staggering increase in call options trading, with investors snapping up 539,824 contracts, marking a 286% jump ...